RSNA: CT Images Differentiate Thymus Cancers from Benign Lesions

Share this content:

(ChemotherapyAdvisor)–Computed tomography (CT) image features might be useful in differentiating thymus malignancies from benign lesions, possibly allowing fewer unnecessary invasive procedures, according to a retrospective study presented at the Radiological Society of North America (RSNA)'s 2012 Scientific Assembly and Annual Meeting in Chicago, IL.

“Absence of intralesional fat, a left or right of midline location, and a non-thymic shape were (independently) statistically associated with malignant thymic lesions,” reported lead author Aoife McErlean MBBCh, FFRRCSI, of the Radiology Department, Children's University Hospital, in Dublin, Ireland, and coauthors. “Patients who are older, had infiltration of the mediastinal fat and increased lesion short axis dimension had greater odds of a malignant lesion.”

Increasing use of CT has lead to more frequent incidentally-identified asymptomatic thymic lesions in the anterior mediastinum, the authors noted. Detection of preclinical or benign ‘incidentalomas' can lead to unnecessary invasive biopsies and interventions, so the authors studied if CT features are useful in distinguishing between benign thymic lesions and early-stage malignancies of the thymus.

Preoperative CT images for 66 patients who had undergone thymectomy during 2007-2010 were reviewed by radiologists blinded to the patients' pathology results. Image assessments followed International Thymic Malignancy Interest Group (ITMIG) definitions.

“There were 38 (58%) malignant and 28 (42%) benign thymic lesions in the study group,” the authors reported. “Malignant tumors were larger, with a median short axis dimension of 31.0mm compared to 19.5mm for benign lesions (P=0.028), and were more frequently located in the left or right of the anterior mediastinum as opposed to the midline (P =0.029). Intralesional fat was seen exclusively in benign thymic masses (P =0.002).”

Patients with thymic malignancies were significantly older (median age, 60.0 years) than those with benign-lesions (median age, 49.5 years; P=0.007), they reported.

“Seven benign (25%) but only 1 (2.6%) malignant tumors had a thymic (triangular) shape (P=0.023),” the authors noted. “In multivariate analysis, patient age, short axis dimension and infiltration of the mediastinal fat were significant independent predictors of malignant pathology.”

“Some CT features of thymic masses may be helpful in suggesting a benign etiology, therefore possibly avoiding unnecessary invasive procedures,” they concluded.

Abstract

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters



Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs